Pluri Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Pluri Inc. stock issued during period, shares, new issues for the quarter ending 2020-03-31 was 1.68M shares.
- Pluri Inc. stock issued during period, shares, new issues for the quarter ending 2019-12-31 was 1.20M shares.
- Pluri Inc. stock issued during period, shares, new issues for the quarter ending 2019-09-30 was 439.90K shares.
- Pluri Inc. stock issued during period, shares, new issues for the quarter ending 2014-06-30 was 162.25K shares.
- Pluri Inc. stock issued during period, shares, new issues for fiscal 2015 was 6.80M shares, a 161.94% increase from fiscal 2014.
- Pluri Inc. stock issued during period, shares, new issues for fiscal 2014 was 2.60M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2020-03-31 | 1.68M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-05-11 | |
| 2019-12-31 | 1.20M shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-02-06 | |
| 2019-09-30 | 439.90K shares 10-Q · filed 2019-11-07 | |
| 2015-06-30 | 6.80M shares 10-K · filed 2017-09-07 | |
| 2014-06-30 | 162.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2015-09-09 | 2.60M shares 10-K · filed 2015-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B |